Follow
Laura Mitchell
Laura Mitchell
Alchemab Therapeutics Ltd
No verified email
Title
Cited by
Cited by
Year
Comparative analysis of nanobody sequence and structure data
LS Mitchell, LJ Colwell
Proteins: Structure, Function, and Bioinformatics 86 (7), 697-706, 2018
1752018
Analysis of nanobody paratopes reveals greater diversity than classical antibodies
LS Mitchell, LJ Colwell
Protein Engineering, Design and Selection 31 (7-8), 267-275, 2018
1062018
Deciphering the language of antibodies using self-supervised learning
J Leem, LS Mitchell, JHR Farmery, J Barton, JD Galson
Patterns 3 (7), 2022
822022
Rate of asparagine deamidation in a monoclonal antibody correlating with hydrogen exchange rate at adjacent downstream residues
JJ Phillips, A Buchanan, J Andrews, M Chodorge, S Sridharan, L Mitchell, ...
Analytical chemistry 89 (4), 2361-2368, 2017
462017
Pragmatic mAb lead molecule engineering from a developability perspective
B Chi, G De Oliveira, T Gallagher, L Mitchell, L Knightley, CC Gonzalez, ...
Biotechnology and Bioengineering 118 (10), 3733-3743, 2021
32021
A FULLY human bispecific antibody functionally rescues factor VIII deficiency ex vivo
W Wang, J Blackwood, R Magliozzi, L Moraes, J Hollins, A Sinopoli, B Chi, ...
Blood 134, 2410, 2019
12019
Using data to characterise the relationship between nanobody sequence, structure and function
LS Mitchell
University of Cambridge, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–7